Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Rivastigmine 3mg capsules
0411000E0AAABAB
|
Rivastigmine | Rivastigmine | Central Nervous System | 24,210 |
|
Rivastigmine 9.5mg/24hours transdermal patches
0411000E0AAAGAG
|
Rivastigmine | Rivastigmine | Central Nervous System | 23,359 |
|
Rivastigmine 1.5mg capsules
0411000E0AAAAAA
|
Rivastigmine | Rivastigmine | Central Nervous System | 17,715 |
|
Rivastigmine 4.6mg/24hours transdermal patches
0411000E0AAAFAF
|
Rivastigmine | Rivastigmine | Central Nervous System | 10,505 |
|
Rivastigmine 4.5mg capsules
0411000E0AAACAC
|
Rivastigmine | Rivastigmine | Central Nervous System | 10,114 |
|
Rivastigmine 6mg capsules
0411000E0AAADAD
|
Rivastigmine | Rivastigmine | Central Nervous System | 7,370 |
|
Rivastigmine 13.3mg/24hours transdermal patches
0411000E0AAAIAI
|
Rivastigmine | Rivastigmine | Central Nervous System | 5,429 |
|
Rivastigmine 2mg/ml oral solution sugar free
0411000E0AAAEAE
|
Rivastigmine | Rivastigmine | Central Nervous System | 916 |
|
Rivastigmine 2mg/ml oral solution
0411000E0AAAHAH
|
Rivastigmine | Rivastigmine | Central Nervous System | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.